Valerio Therapeutics SA
PAR:ALVIO

Watchlist Manager
Valerio Therapeutics SA Logo
Valerio Therapeutics SA
PAR:ALVIO
Watchlist
Price: 0.1665 EUR 20.65% Market Closed
Market Cap: 81.4m EUR

Wall Street
Price Targets

ALVIO Price Targets Summary
Valerio Therapeutics SA

There are no price targets for ALVIO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Valerio Therapeutics SA Competitors:
Price Targets
LTRN
Lantern Pharma Inc.
556% Upside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
11% Upside
UTHR
United Therapeutics Corp
5% Upside
RPTX
Repare Therapeutics Inc
19% Upside
6160
Beigene Ltd
28% Upside
KMDA
Kamada Ltd
89% Upside
BMEA
Biomea Fusion Inc
433% Upside
688382
InventisBio Co Ltd
84% Upside

Revenue
Forecast

Revenue Estimate
Valerio Therapeutics SA

For the last 13 years the compound annual growth rate for Valerio Therapeutics SA's revenue is -4%. The projected CAGR for the next 2 years is 247%.

-4%
Past Growth
247%
Estimated Growth
Estimates Accuracy
6%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Valerio Therapeutics SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Valerio Therapeutics SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-91%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ALVIO's stock price target?
Not Available

ALVIO doesn't have any price targets made by Wall Street professionals.

What is Valerio Therapeutics SA's Revenue forecast?
Projected CAGR
247%

For the last 13 years the compound annual growth rate for Valerio Therapeutics SA's revenue is -4%. The projected CAGR for the next 2 years is 247%.

Back to Top